p95HER2-CAR T cell targeting metastatic breast cancer on-Target, but no off-Tumor
- Project leader: Esmaeil Dorraji, Institute for Cancer Research, Radium Hospital, Oslo University Hospital
- Team members: Jon Amund Kyte, Aina Rengmark, Eivind Roverud, Magdalena Gjefle and Bj?rn Naume
Targeting the TREM2-receptor for Alzheimer’s disease therapy
- Project leader: Lars Nilsson, Pharmacology, Institute of Clinical Medicine, UiO
- Team members: Vibeke ?rskog, Sandra Kühn, Jo Klaveness
rOoC (revolving Organ-on-chip platform)
- Project leader: Dr. Alexandra Aizenshtadt, Centre of Excellence - Hybrid Technology Hub, University of Oslo
- Team members: Dr. Mathias Busek, Chencheng Wang, Prof. Steven Ray Haakon Wilson, Prof. Stefan Krauss, Dr. Hanne Scholz
Broadly reactive vaccines against seasonal infectious disease
- Project leader: Kristin Lunder Klausen PhD candidate, University of Oslo and Oslo University Hospital
- Team member: Dr. Gunnveig Gr?deland, UiO
Tankyrase inhibition for therapy of fibrotic diseases
- Project leader: Shoshy Alam Brinch, Hybrid Technology Hub, UiO and Department of Immunology and Transfusion Medicine, Oslo University Hospital
- Team members: Jo Waaler (OUS/UiO) and Stefan Krauss (UiO/OUS)
Novel Treatment for Patients with Glioblastoma
- Project leader: Postdoc Aleksandra Dukic, Institute of Clinical Medicine, UiO and Institute for Cancer Research, Oslo University Hospital
- Team members: Professor Kjetil Taskén, Associate Professor Rafi Ahmad and Inven2
Development of a new product to relieve the symptoms of dry mouth
- Project leader: Professor Marianne Hiorth, Department of Pharmacy, UiO
- Team members: PhD student Julie Frig?rd, Professor Gro Smistad, Professor Janicke Liaaen Jensen and Professor Hilde Kanli Galtung
Targeting transcriptional addictions in glioblastoma
- Project leader: Dr. Deo Pandey, Dept. of microbiology, Oslo University Hospital
- Team members: Silje Lier, UiO
A solution to the kneecap fracture problem
- Project leader: MD PhD Hendrik Fr?lich Stange Fuglesang, Orthopaedic department, Akershus University Hospital
- Team members: MD Max J. Temmesfeld
A Novel Biomarker for Antibody Drug Conjugates
- Project leader: Dr. Anette Weyergang, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital
- Team members: Dr. Kristian Berg and Dr. Olav Engebr?ten, The Radiumhospital Research Foundation
MyFood – a decision support system to prevent and treat disease-related malnutrition
- Project leader: PhD student Mari Mohn Paulsen, Department of Nutrition, Institute of Basic Medical Sciences, UiO
- Team members: Professor Lene Frost Andersen, Dagfinn Bergsager and Gard O. S. Thomassen
Inhibition of aortic valve calcification
- Project leader: Professor K?re-Olav Stensl?kken, Institute of Basic Medical Sciences, UiO
- Team members: Professor emeritus Jarle Vaage and Dr. Arsenii Zabernyk
A medical device for obesity treatment
- Project leader: Christer T?nnesen, Department of Health Management and Health Economics (HELED), The Institute of Health and Society, UiO and Oslo University Hospital
- Team members: Nj?l H?stm?lingen, Professor Michael Bretthauer, Associate Professor Magnus L?berg, Professor II Lars Aabakken, Marianne Lyngra and Yuichi Mori
Human antibodies for therapeutic, selective Notch targeting in rheumatoid arthritis
- Project leader: Guttorm Haraldsen, center leader, UiO
- Team members: Anita Kavlie, Stig Krüger and Katarzyna Marciniak
Healthy soils for a healthy life
- Project leader: Kamran Shalchian-Tabrizi, UiO
- Team members: The research group MORPHOPLEX
- Watch Shalchian-Tabrizi?s presentation at the SPARK Norway kick-off 13 February 2018
A novel vaccine technology platform
- Project leader: Malin Bern, postdoc, Oslo University Hospital (OUS)
- Team members: Jan Terje Andersen (UiO) and Inger Sandlie (UiO)
High-Performance Cyclotron Target for Gallium-68
- Project leader: Bent W. Schoultz, Associate Professor, Norwegian Nuclear Research Center, Dep. of physics, UiO
- Team members: Andreas G?rgen and Sunniva Siem (UiO) as well as Elin Melby and Bjarne Tvete (Inven2)
A biologic therapeutic for pulmonary fibrosis
- Project leader: Ole J?rgen Kaasb?ll, researcher, Inst. clin. med., UiO
- Team member: H?vard Attramadal, Inst. clin. med. (UiO)
Novel treatment for heart failure
- Project leader: Maria Vistnes, postdoc, Inst. clin. med. (UiO)
- Team member: Geir Christensen (OUS and UiO)
- Watch Vistnes' presentation at the Oslo Life Science Conference 2019
IVF FitTM: Optimising in vitro fertilisation hormone dosage
- Project leader: Ana Lobato-Pascual, Reproductive Medicine Department, OUS
- Team members: Péter Fedorcsák (OUS and UiO), Mei Ling Lim (Karoliska Institutet), Vidar Ulset (startup entrepreneur) and Krister Andersson (UiO)
- Watch Lobato-Pascual's and Anderssons' presentation at the Oslo Life Science Conference 2019
A novel strategy to tailor the pharmacokinetics of IgA antibodies
- Project leader: Simone Mester, Department of Biosciences, Faculty of Mathematics and Natural Sciences, UiO
- Team members: Inger Sandlie (UiO) and Jan Terje Andersen (OUS)
- Watch Mester's presentation at the Oslo Life Science Conference 2019
Tankyrase inhibition in cancer immune therapy
- Project leader: Jo Waaler, Faculty of Medicine, UiO
- Team member: Stefan Krauss, (UiO and OUS)
Novel therapy for currently untreatable hypertension
- Project leader: Henriette Andresen, Department of Pharmacology and Institute for Experimental Medical Research, Institute of Clinical Medicine, UiO
- Team members: Lise Román Moltzau (UiO) Finn Olav Levy (UiO) and Alessandro Cataliotti (UiO)
- Watch Andresen?s presentation at the SPARK Norway kick-off 13 February 2018
Restoration of a functional urinary bladder using cutting-edge technology
- Project leader: Jean-Luc Boulland, Norwegian Center for Stem Cell Research, UiO/OUS
- Team members: Mark Züchner (OUS), Henning Andreas Haga (NMBU), Andreas Lervik (NMBU), Vanessa Bettembourg (NMBU), Joel Glover (UiO) and Ole-Jakob Nilsen (OUS)
- Watch Boulland's presentation at the Oslo Life Science Conference 2019
Novel therapy for ischemic reperfusion injury
- Project leader: Ana Isabel Costa Calejo, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, UiO
- Team members: Kjetil Tasken (UiO/OUS), Jo Klaveness (UiO), Ivar Sjaastad (OUS), Magnus Aronsen (UiO/OUS), Mohammed Amarzguioui (Inven2) and Kristin Sandereid (Inven2)
- Watch Calejo?s presentation at the SPARK Norway kick-off 13 February 2018
RACeR: Improvement of A Genetic Tool that Enhances Homology Dependent Gene Repair
- Project leader: Francesca Ferrucci (from March 2019), Oslo University Hospital, Department of Microbiology
- Team members: Caroline K?ster, Deo Pandey, Terezia Prikrylova, Rune Forstr?m and Arne Klungland
- Watch former project leader Adam Robertson?s presentation at the SPARK Norway kick-off 13 February 2018
Petomics: a commercial Norwegian microbiome service for performance animals and pets
- Project leader: P?l Trosvik, UiO
- Team member: Eric Jacques de Muinck
Influenza vaccine that can be rapidly produced to counter an emerging pandemic threat
- Project leader: Gunnveig Gr?deland, UiO
- Team member: Bjarne Bogen
- Watch Gr?deland?s presentation at the main event of Oslo Life Science 2018
- Watch Gr?deland's presentation on a public event of the Oslo Life Science Conference 2019 (in Norwegian)
Targeted pharmacological treatment of ventricular arrhythmias
- Project leader: Magnus Aronsen, UiO
- Team member: Jonas Skogestad
- Watch Skogestad?s presentation at the SPARK Norway kick-off 13 February 2018